This inventor holds 4 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Yale University, Cx Therapeutics, Inc., Tufts Medical Center. Active years: 2010-2026.
Location History:
- Madison, CT (US) (2010)
- Newton, MA (US) (2011 - 2014)
Company Filing History:
3 out of 1,363 
1 out of 1 
1 out of 86 Years Active: 2010-2026
Title: The Innovations of Errol Norwitz
Introduction
Errol Norwitz is a notable inventor based in Newton, MA (US), recognized for his contributions to medical technology. With a total of 4 patents, he has made significant strides in the field of healthcare, particularly in maternal-fetal medicine.
Latest Patents
Norwitz's latest patents include a cervical support system and a method of use, which is designed for use in cerclage procedures. This innovative apparatus features a flexible support member and multiple compression members that facilitate the application of radial pressure against the cervix during the procedure. Another significant patent addresses the diagnosis of preeclampsia. This invention provides methods and compositions for detecting and monitoring angiogenic factors in urine samples from pregnant women. It aims to assess the risk of developing complications during pregnancy, including hypertensive disorders.
Career Highlights
Throughout his career, Errol Norwitz has worked with prestigious institutions such as Yale University and Tufts University. His work has focused on advancing medical technologies that improve patient outcomes in pregnancy-related complications.
Collaborations
Norwitz has collaborated with esteemed colleagues, including Catalin S Buhimschi and Irina Buhimschi, contributing to the advancement of research in his field.
Conclusion
Errol Norwitz's innovative contributions to medical technology, particularly in maternal-fetal health, highlight his commitment to improving healthcare outcomes. His patents reflect a dedication to addressing critical issues in pregnancy, showcasing the impact of his work in the medical community.